Neuroblastoma, a cancer of the developing nervous system, has long challenged researchers because its behavior can vary dramatically from one patient to another. Some tumors respond well to treatment, while others grow aggressively, spread rapidly, and return despite intensive therapy. A new study published in the British Journal of Cancer examines one of the most important genetic features associated with this disease: changes affecting the long arm of chromosome 17, known as 17q. The research presents chromosome 17q as more than a passive marker of cancer progression, describing it as a functional region where the demands of rapid DNA replication collide with the cell’s need to preserve genomic stability.

Chromosome 17q is frequently altered in neuroblastoma, particularly through the gain of additional genetic material. In cancer biology, such gains can increase the dosage of genes that support tumor growth, survival, or resistance to treatment. Yet the consequences are not necessarily uniform across the entire chromosome. A duplicated region may contain genes with opposing effects: some may help malignant cells divide, while others may create vulnerabilities by placing excessive pressure on the machinery responsible for copying DNA. The study by Hilgert, Depestel, Van Roy and colleagues investigates this functional complexity rather than treating 17q gain as a single, indivisible event.

DNA replication is the process by which a cell copies its genome before dividing. This operation must proceed rapidly but with remarkable accuracy. When replication forks—the molecular structures that move along DNA during copying—slow down, stall, or collapse, cells experience replication stress. Replication stress can arise when cancer cells divide too quickly, when DNA contains difficult-to-copy sequences, or when the supply of nucleotides and other replication components becomes insufficient. If unresolved, stalled replication forks can generate DNA breaks and rearrangements, helping tumors evolve while also threatening the survival of the cells that carry them.

The new work focuses on how genetic elements within 17q influence this balance. A region that promotes proliferation may simultaneously intensify replication stress, creating a biological paradox. Tumor cells benefit from increased growth signals, but they must also develop mechanisms to tolerate the resulting damage. This dependence can become a weakness: cancer cells operating close to the limits of replication may rely heavily on DNA repair pathways and checkpoint systems that normal cells use less intensively. Disrupting those support systems could selectively harm tumor cells, an idea that has become central to the development of targeted cancer treatments.

The researchers describe a “functional landscape” for chromosome 17q, suggesting that the region should be understood through the combined activity of its genes and regulatory elements. Genes do not act in isolation. Their effects depend on gene dosage, cellular context, interactions with other genomic regions, and the stage of tumor development. In neuroblastoma, these relationships may determine whether a 17q alteration produces a viable, treatment-resistant cancer cell or instead creates so much replication difficulty that the cell becomes vulnerable to damage and death. Mapping these relationships offers a more precise view of why the same broad chromosomal change can have different consequences in individual tumors.

This perspective is especially important because neuroblastoma often develops from immature cells of the peripheral nervous system. During early development, these cells naturally undergo tightly regulated programs of growth, migration, and differentiation. Cancer can emerge when those programs are disrupted, allowing cells to continue dividing instead of maturing into specialized nerve-related cells. Additional chromosomal alterations may then reinforce the malignant state. By connecting 17q abnormalities with replication stress and genome maintenance, the study places a major neuroblastoma feature within the wider biology of developmental cancer.

Genomic stability refers to the ability of a cell to copy and preserve its DNA without accumulating excessive mutations or structural changes. Cancer cells frequently compromise this stability, producing an unstable genome that can accelerate adaptation. However, instability has limits. Too little DNA damage may not generate enough diversity for a tumor to evolve, while too much can trigger cell death or permanent growth arrest. The study’s central concept is that 17q alterations may push neuroblastoma cells toward this dangerous threshold, forcing them to balance accelerated growth against the risk of catastrophic replication failure.

The findings could influence how researchers think about treatment strategy. If specific 17q-associated activities make tumor cells dependent on replication-stress responses, therapies aimed at DNA damage checkpoints or repair enzymes might be especially effective in selected neuroblastomas. Such approaches could potentially be combined with existing treatments, including chemotherapy, which already damages DNA but can also harm healthy tissues. The challenge will be identifying which tumors truly depend on particular repair mechanisms and determining how to target those dependencies without increasing toxicity. A functional map of 17q could help move treatment decisions beyond the simple presence or absence of a chromosomal gain.

The study also highlights why cancer genomes should not be interpreted solely through large-scale structural changes. A chromosomal gain may be clinically useful as a prognostic signal, but its biological meaning depends on the genes and pathways it affects. By examining how chromosome 17q contributes to replication stress and genome protection, the researchers provide a framework for understanding why this region is repeatedly selected during neuroblastoma evolution. Their work points toward a future in which genetic alterations are assessed not only as labels of risk, but as clues to the specific pressures that keep cancer cells alive—and the vulnerabilities that may ultimately bring them down.

Subject of Research: Functional effects of chromosome 17q alterations, replication stress, and genomic stability in neuroblastoma

Article Title: A functional landscape for chromosome 17q in neuroblastoma: balancing replication stress and genomic stability

Article References: Hilgert, E., Depestel, L., Van Roy, N. et al. “A functional landscape for chromosome 17q in neuroblastoma.” British Journal of Cancer (2026). https://doi.org/10.1038/s41416-026-03569-w

Image Credits: AI Generated

DOI: 10.1038/s41416-026-03569-w

Keywords: Neuroblastoma, chromosome 17q, replication stress, genomic stability, DNA replication, DNA repair, cancer genetics, tumor evolution, developmental cancer

A quiet shift in silicon manufacturing could be taking shape inside a new study on porous reaction-bonded silicon nitride, a ceramic material valued for its strength, thermal stability and resistance to chemical attack. Researchers T.G. Aguirre, E. Cakmak, M.D. Richardson and colleagues are investigating how the size of additively manufactured silicon components affects their conversion into silicon nitride through a pressureless nitriding process. Published in npj Advanced Manufacturing, the work connects binder jet 3D printing with a manufacturing route that could make complex ceramic structures easier to produce.

The central idea is deceptively simple: print a component from silicon powder, then expose it to nitrogen so that the silicon reacts and forms silicon nitride. In practice, however, the transformation is governed by a network of interacting physical and chemical processes. Nitrogen must penetrate the part, reach reactive silicon surfaces and diffuse through newly formed ceramic layers. Heat must also move through the structure, while gases generated or trapped during processing must escape. As component dimensions change, these processes can behave very differently.

Binder jet additive manufacturing offers a distinctive route for creating such parts. Instead of melting powder with a laser or electron beam, the process selectively deposits a liquid binder to join powder particles layer by layer. The resulting “green” component is then typically dried and thermally treated to remove the binder, leaving a fragile, porous body. For silicon-based structures, that interconnected porosity can become a processing advantage, allowing nitrogen to travel through the material during the subsequent reaction.

The researchers’ focus on size effects addresses a major challenge in scaling ceramic additive manufacturing from laboratory specimens to useful components. A thin printed sample may nitridize relatively quickly because nitrogen has only a short distance to travel. A thicker or larger part presents a far more demanding environment. Its interior can receive nitrogen more slowly, and the reaction front may progress unevenly from the outer surface inward. Differences in heating rate, temperature distribution and gas transport can produce variations in conversion, density and final microstructure.

The term “pressureless nitriding” is crucial to the study’s technological appeal. Many advanced ceramic manufacturing methods depend on external pressure, specialized furnaces or high-energy consolidation steps to achieve the desired structure. A pressureless route instead relies on controlled heating and the chemical affinity between silicon and nitrogen. If the reaction can be managed uniformly, manufacturers could potentially create intricate silicon nitride components without applying mechanical pressure during conversion, simplifying equipment requirements and expanding the range of printable geometries.

Silicon nitride is an especially attractive target because it combines several properties that are difficult to obtain in a single engineering material. It can withstand high temperatures, resist wear and corrosion, and maintain useful mechanical performance under demanding conditions. Those characteristics have made silicon nitride relevant to applications ranging from bearings and cutting tools to heat-resistant components and advanced energy systems. A porous version offers additional possibilities, including lightweight structures, filtration, thermal management and engineered surfaces where controlled pathways through the material are valuable.

The study’s attention to porosity is equally important. In reaction-bonded ceramics, pores are not merely defects; they can serve as channels for reactant transport. At the same time, excessive or poorly distributed porosity can weaken the final component and interfere with complete conversion. The scientific challenge is therefore to balance openness and strength. The printed silicon body must remain permeable enough for nitrogen to reach its interior, while the reaction must generate a coherent silicon nitride framework rather than leaving unreacted silicon or creating damaging gradients.

By examining components of different sizes, the researchers are addressing a question with direct implications for industrial design: can processing rules developed for small printed samples be applied to larger parts? The answer depends on how reaction kinetics, diffusion and heat transfer scale with geometry. A process that appears reliable in a small coupon may produce a different result in a thick wall, enclosed channel or complex lattice. Understanding those differences can help engineers determine allowable dimensions, optimize furnace schedules and design structures around the chemistry of nitridation rather than treating manufacturing as a purely geometric exercise.

The broader significance of the work lies in the convergence of three fields: powder-based additive manufacturing, reaction-bonded ceramics and transport-driven materials processing. Instead of printing a finished ceramic directly, the approach uses additive manufacturing to create a carefully engineered precursor and then transforms it chemically. That strategy could unlock shapes that are difficult to machine from dense silicon nitride, while reducing the need for conventional molds and tooling. As manufacturers seek lighter, more complex and more resource-efficient components, controlling size-dependent reactions may become as important as improving printer resolution.

The research arrives at a moment when additive manufacturing is moving beyond demonstrations of intricate shapes toward repeatable production of functional materials. Its emphasis on pressureless nitriding of binder jet additively manufactured silicon highlights a practical bottleneck often hidden behind spectacular 3D-printing images: the printed object is only the beginning. The final performance depends on what happens during post-processing, when gases, heat and chemical reactions determine the internal structure. By clarifying how component size influences that transformation, Aguirre, Cakmak, Richardson and their collaborators are helping map a route from powder and binder to porous silicon nitride parts designed for the high-temperature technologies of the future.

Subject of Research: Porous reaction-bonded silicon nitride produced through pressureless nitriding of binder jet additively manufactured silicon, with a focus on size effects.

Article Title: Porous reaction-bonded silicon nitride: Size effects for pressureless nitriding of binder jet additively manufactured silicon

Article References: Aguirre, T.G., Cakmak, E., Richardson, M.D. et al. “Porous reaction-bonded silicon nitride: Size effects for pressureless nitriding of binder jet additively manufactured silicon.” npj Advanced Manufacturing (2026). https://doi.org/10.1038/s44334-026-00110-y

Image Credits: AI Generated

DOI: 10.1038/s44334-026-00110-y

Keywords: Silicon nitride, reaction-bonded ceramics, pressureless nitriding, binder jet additive manufacturing, silicon, porous materials, size effects.

Fuchs endothelial corneal dystrophy, a progressive disorder that can gradually cloud the cornea and impair vision, may be driven by a cellular process more complex than simple cell loss. A new study published in Cell Death Discovery reports that ultraviolet-A light can induce chronic hyperploidization in corneal endothelial cells, triggering changes associated with fibrosis. The findings connect long-term genome abnormalities in post-mitotic cells to the structural deterioration observed in this increasingly recognized eye disease.

The cornea depends on a thin inner layer of endothelial cells to maintain its transparency. These cells regulate the movement of fluid between the cornea and the anterior chamber of the eye, preventing the tissue from becoming waterlogged. Unlike many cell types, human corneal endothelial cells have limited ability to divide and replenish themselves. When they are damaged or lost, neighboring cells may enlarge and stretch to cover the affected area, but this compensation has limits. In Fuchs endothelial corneal dystrophy, the endothelial layer progressively becomes dysfunctional, allowing fluid accumulation and producing corneal swelling, haze and visual distortion.

The study focuses on hyperploidization, a condition in which cells acquire extra sets or copies of chromosomes. In a healthy cell cycle, DNA is replicated and then evenly distributed when a cell divides. Post-mitotic cells, however, are not expected to continue cycling through repeated rounds of DNA replication. If DNA replication occurs without successful cell division, the result can be a cell with an enlarged genome and multiple chromosome sets. This state, known as polyploidy or hyperploidization depending on its extent and context, can alter cell size, metabolism, gene activity and responses to stress.

The researchers investigated how ultraviolet-A, or UVA, light affects cells associated with Fuchs endothelial corneal dystrophy. UVA has a longer wavelength than ultraviolet-B and can penetrate biological tissues more deeply. Although the eye possesses protective mechanisms, persistent or excessive exposure to light-generated stress can damage cellular components, including DNA, proteins and mitochondria. The study indicates that UVA exposure does not merely cause an acute injury that cells either repair or fail to survive. Instead, it can establish a chronic hyperploid state in cells that no longer divide normally.

That distinction is important because a cell can remain alive while becoming increasingly dysfunctional. Hyperploid cells may continue to produce proteins, communicate with neighboring cells and modify their surrounding environment, even as their enlarged genomes disrupt normal regulation. In the corneal endothelium, such persistent abnormalities could interfere with the machinery responsible for maintaining fluid balance and tissue transparency. The research links this long-lasting cellular state to the activation of fibrotic processes, suggesting that damaged endothelial cells may help remodel the cornea rather than simply disappearing.

Fibrosis is the formation or accumulation of excessive connective-tissue components, particularly extracellular matrix proteins such as collagens. During wound healing, matrix production can provide temporary structural support. When the response persists, however, the tissue can stiffen, become disorganized and lose its normal optical properties. In the context of Fuchs endothelial corneal dystrophy, fibrosis may contribute to the loss of corneal clarity and the progression of visual impairment. The study’s central message is that chronic hyperploidization may act as an upstream signal that pushes post-mitotic cells toward this pathological remodeling.

The findings also help explain why a disease affecting a specialized, non-dividing cell population can progress over time. A conventional view of cellular damage often emphasizes apoptosis, necrosis or the gradual depletion of functional cells. The new work highlights another possibility: injured cells may survive in a permanently altered condition and actively influence disease progression. By retaining metabolic activity while carrying abnormal quantities of DNA, these cells could produce signals that encourage inflammation, matrix deposition or changes in the behavior of nearby cells.

The UVA connection raises questions about how environmental stress interacts with inherited susceptibility. Fuchs endothelial corneal dystrophy has genetic and age-related components, and the disease does not arise from a single universal cause. The study does not establish that UVA exposure alone causes the disorder, but it provides a mechanism through which light-associated stress could worsen cellular instability in vulnerable corneal tissue. This may help researchers examine whether cumulative exposure, cellular antioxidant capacity and pre-existing genetic changes combine to determine how rapidly the disease advances.

From a treatment perspective, the work points toward targets beyond replacing lost endothelial cells. Future strategies might seek to prevent abnormal DNA replication, stabilize genome integrity, suppress the fibrotic signals released by hyperploid cells or protect the corneal endothelium from chronic light-induced stress. Such approaches would require careful testing, because polyploidy can serve useful roles in some normal tissues, and broadly blocking cell-cycle or repair pathways could produce harmful effects. The challenge will be to distinguish pathological hyperploidization from adaptive genome changes that help cells survive.

The study ultimately presents Fuchs endothelial corneal dystrophy as a disease of cellular identity as well as cellular survival. UVA-induced chronic hyperploidization appears to place post-mitotic corneal endothelial cells in a persistent state of genomic imbalance, where they can contribute to fibrosis and tissue failure. By connecting light stress, abnormal DNA content and corneal scarring, the research offers a new framework for understanding why the disease can continue even after the initial injury has passed—and provides a potential roadmap for therapies designed to interrupt the process before vision is permanently compromised.

Subject of Research: Ultraviolet-A light-induced chronic hyperploidization and fibrosis in post-mitotic corneal endothelial cells affected by Fuchs endothelial corneal dystrophy

Article Title: Ultraviolet-A light-induced chronic hyperploidization causes fibrosis in post-mitotic cells affected by Fuchs endothelial corneal dystrophy

Article References: Adhikari, Y., Parekh, M., Deshpande, N. et al. Ultraviolet-A light-induced chronic hyperploidization causes fibrosis in post-mitotic cells affected by Fuchs endothelial corneal dystrophy. Cell Death Discov. (2026). https://doi.org/10.1038/s41420-026-03292-8

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41420-026-03292-8

Keywords: Fuchs endothelial corneal dystrophy, ultraviolet-A, UVA, hyperploidization, polyploidy, corneal endothelial cells, fibrosis, post-mitotic cells, genome instability, corneal disease

We’re asleep an average of about 26 years of our life! Most people have a sense that sleep is important.

Source